Paz-Ares L, et al. Overall survival with durvalumab plus etoposide-platinum in first-line extensive-stage SCLC: results from the CASPIAN study. Abstract PL02.11. WCLC 2019, 7-10 september, Barcelona, Spanje.
Lokale toediening CTLA-4-remmer bij melanoom effectiever dan infuus
jul 2022 | Dermato-oncologie, Immuuntherapie